Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Baller, D
Right arrow Articles by Horstkotte, D
Right arrow Search for Related Content
PubMed
Right arrow Articles by Baller, D
Right arrow Articles by Horstkotte, D
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The European Society of Cardiology

Myocardial oxygen consumption and perfusion before and after cardiac resynchronization therapy: experimental observations and clinical implications

D Ballera,*, J Vogta, O Lindnerb, B Lampa, J Holzingerb, A Kammeierb, P Wieleppb, W Burchertb and D Horstkottea

a Department of Cardiology, Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany
b Institute for Molecular Biophysics, Radiopharmacology, and Nuclear Medicine, Heart Centre North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany

Received 3 May 2004; accepted 24 May 2004.

* D. Baller, MD, PhD, Department of Cardiology, Heart Centre North Rhine-Westphalia, Georgstr. 11, 32545 Bad Oeynhausen, Germany. Tel.: +49-5731-972194; fax: +49-5731-971859
akohlstaedt{at}hdz-nrw.de

Abstract

Aims Experimental studies indicated unfavourable effects on myocardial energetics and efficiency under asynchronous ventricular stimulation, also shown for left bundle branch block (LBBB) pattern. We noninvasively analyzed the effects on myocardial oxygen consumption (MVO2), perfusion (MBF) and pressure work efficiency by positron emission tomography (PET) before and after resynchronization therapy (CRT) in 31 patients with dilated cardiomyopathy (DCM) and LBBB.

Methods 31 patients (19 males, 12 females) with DCM were studied at baseline and 3–4 months follow-up. Baseline characteristics: age 61±7 years; NYHA class 3.0±0.4, ejection fraction 22.1±7.1%, QRS duration 187±19 ms. MVO2 and MBF were measured from 11C-acetate kinetics with PET by a one-compartment model. MVO2 and MBF were normalized to rate pressure product (RPP) to account for different pressure loads and predicted energy demands.

Results Global MVO2 assessed from 11C-acetate clearance did not change significantly between baseline and follow-up (0.080±0.015/min vs. 0.082±0.020/min). RPP-normalized MVO2 significantly decreased after CRT (0.072±0.018/min) vs. baseline (0.081±0.017/min; ). Normalized MBF showed a concomitant decrease from 0.51±0.11 to 0.46±0.1 ml/min/g; after CRT. Regional MVO2 significantly decreased in the lateral wall (0.083±0.020/min) compared to baseline (0.090±0.018/min; ) and increased in the septum (0.081±0.022/min vs. 0.073±0.014/min at baseline).

Conclusion 1. CRT does not increase absolute global MVO2 in the short-term. 2. RPP-normalized MVO2 even decreased suggesting improved pressure work efficiency. 3. CRT leads to a reverse remodelling of regional myocardial oxygen dysbalance.

Key Words: Heart failure • Resynchronization therapy • Pacing • Myocardial oxygen c onsumption • Perfusion • PET


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.